Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 7, 2014, Pages e448-e451

  Aguilera, Dolly ^a   Flamini, Robert ^b   Mazewski, Claire ^a   Schniederjan, Matthew ^a   Hayes, Laura ^b   Boydston, William ^c   Castellino, Robert C ^a   MacDonald, Tobey J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neurology ^*  (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Everolimus; SEGA; Spinal cord; Tuberous sclerosis

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; EVEROLIMUS; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; OXCARBAZEPINE; PROTEIN S 100; SYNAPTOPHYSIN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; RAPAMYCIN;

ADOLESCENT; ANAMNESIS; ARTICLE; BRAIN INTERVENTRICULAR FORAMEN; BRAIN REGION; BRAIN VENTRICLE TUMOR; CANCER GRADING; CANCER GROWTH; CANCER SURGERY; CASE REPORT; CONSTIPATION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; FAILURE TO THRIVE; GENERAL CONDITION DETERIORATION; GIANT CELL TUMOR; GLIOBLASTOMA; HEART RHABDOMYOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; KETOGENIC DIET; KIDNEY HEMANGIOMYOLIPOMA; LIMITED MOBILITY; LOW BACK PAIN; LUMBAR SPINAL CORD; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL INTOLERANCE; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADICULOPATHY; RHABDOMYOMA; SPINAL CORD BIOPSY; SPINAL CORD METASTASIS; SUBEPENDYMOMA; TEMPORAL LOBECTOMY; TONIC CLONIC SEIZURE; TUBEROUS SCLEROSIS; TUMOR CELL DESTRUCTION; TUMOR VOLUME; ASTROCYTOMA; BRAIN TUMOR; METASTASIS; PATHOLOGY; SPINAL CORD TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; MALE; SIROLIMUS; SPINAL CORD NEOPLASMS; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 84910115574     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000005     Document Type: Article

References (19)

1. Sharma M, Ralte A, Arora R, et al. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Pathology. 2004;36:139-144.
2. Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004;63:1457-1461.
3. Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatr Drugs. 2008;10:299-313.
4. Matsumura H, Takimoto H, Shimada N, et al. Glioblastoma following radiotherapy in a patient with tuberous sclerosis. Neurol Med Chir (Tokyo). 1998;38:287-291.
5. Shepherd CW, Gomez MR, Lie JT, et al. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991;66:792-796.
6. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345-1356.
7. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372:657-668.
8. Zeng LH, Xu L, Gutmann DH, et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;63:444-453.
9. Ehninger D, Han S, Shilyansky C, et al. Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat Med. 2008;14:843-848.
10. Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006;59:490-498.
11. Lam C, Bouffet E, Tabori U, et al. Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors. Pediatr Blood Cancer. 2010;54:476-479.
12. Krueger DA, Care MM, Holland K, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363:1801-1811.
13. Shepherd CW, Scheithauer BW, Gomez MR, et al. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery. 1991;28:864-868.
14. Cuccia V, Zuccaro G, Sosa F, et al. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst. 2003;19:232-243.
15. Telfeian AE, Judkins A, Younkin D, et al. Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Case report. J Neurosurg. 2004;100(suppl Pediatrics):498-500.
16. Bollo RJ, Berliner JL, Fischer I, et al. Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex. J Neurosurg Pediatr. 2009;4:85-90.
17. Painter MJ, Pang D, Ahdab-Barmada M, et al. Connatal brain tumors in patients with tuberous sclerosis. Neurosurgery. 1984;14:570-573.
18. Serkova N, Jacobsen W, Niemann CU, et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol. 2001;133:875-885.
19. Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2012;381:125-132.